U.S. FDA to allow Baltimore plant to resume J&J COVID-19 shot production -WSJ

The U.S. Food and Drug Administration and Johnson & Johnson are expected to announce as early as Friday that contamination problems at a COVID-19 vaccine plant in Baltimore are resolved and that vaccine production can resume, the Wall Street Journal reported on Thursday. The FDA had halted production of J&J’s vaccine at the plant, run […]
Read More

>> CLICK HERE << Get A FREE Copy Of My Special Report
“Can Your Retirement Survive” Today!
There's Absolutely $0 Cost To You!
We Even Pay For Shipping & Handling!
Click Here To Request Your FREE IRS Loophole Guide

This post contains affiliate links. If you use these links to buy something we may earn a commission. Thanks.”

You May Also Like